|
ZNF687 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.005400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.976600E-01 |
| Normal-vs-Stage2 |
6.176800E-01 |
| Normal-vs-Stage3 |
4.382800E-01 |
| Normal-vs-Stage4 |
2.465800E-01 |
| Stage1-vs-Stage2 |
8.229600E-01 |
| Stage1-vs-Stage3 |
5.510600E-01 |
| Stage1-vs-Stage4 |
2.990200E-01 |
| Stage2-vs-Stage3 |
8.472600E-01 |
| Stage2-vs-Stage4 |
5.513200E-01 |
| Stage3-vs-Stage4 |
6.105600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.683000E-01 |
| Normal-vs-AfricanAmerican |
4.955100E-03 |
| Normal-vs-Asian |
5.524800E-01 |
| Caucasian-vs-AfricanAmerican |
1.107750E-02 |
| Caucasian-vs-Asian |
8.980000E-01 |
| AfricanAmerican-vs-Asian |
2.756200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.136800E-01 |
| Normal-vs-Female |
5.888800E-01 |
| Male-vs-Female |
5.040000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.538400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.708800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.633800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.641200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.866440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.892580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.458800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.517000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.001600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.511600E-02 |
| Classical-VS-Follicular |
7.75370000000164E-05 |
| Classical-VS-Other |
1.588000E-01 |
| Classical-VS-Normal |
7.785800E-02 |
| Tall-VS-Follicular |
5.420600E-01 |
| Tall-VS-Other |
6.798800E-01 |
| Tall-VS-Normal |
6.246400E-01 |
| Follicular-VS-Other |
9.428000E-01 |
| Follicular-VS-Normal |
1.905150E-01 |
| Other-VS-Normal |
4.592000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.012800E-01 |
| Normal-vs-N1 |
4.466200E-01 |
| N0-vs-N1 |
2.410200E-01 |
|
|
